| |
|
|
|
Plx Pharma Inc  
|
|
5.82 0.31 (0.06%) |
01-25 16:00 |
|
Open: |
5.52 |
Pre close: |
5.51 |
Target:
|
7.42 
|
|
High: |
5.91 |
Low: |
5.52 |
Resistance:
|
6.36
7.07
|
|
Volume: |
40,726 |
Market Cap: |
81M |
Support:
|
5.20
4.33
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
5.72
 |
MACD |
MACD(12,26):
|
0.06 |
|
MA(20): |
5.84 |
Signal(12,26,9): |
0.13 |
|
MA(100): |
4.44 |
Stochastic Oscillator |
%K(14,3):
|
45.75 |
|
MA(250): |
3.90 |
%D(3): |
46.26 |
|
Average Volume(K) |
3-Month: |
4570
|
52-Week |
High:
|
7.07 |
|
10-Days: |
5123 |
Low: |
1.80 |
|
RSI |
RSI(14):
|
52.46 |
Change(%): |
14.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.180 |
Return on Equity (ttm) |
-226.6 |
Shares Out. (M) |
13.91 |
|
EPS Est. Current Year |
-1.610 |
Return on Assets (ttm) |
-46.5 |
Shares Float (M) |
6.36 |
|
EPS Est. Next Year |
-1.820 |
PEG Ratio |
0.00 |
% Held by Insiders |
5.35 |
|
EPS Est. Next Quarter |
-0.460 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
54.55 |
|
Forward EPS |
-3.840 |
Gross Profit (p.s.) |
0.041 |
Shares Short (K) |
442 |
|
Book Value (p.s.) |
-2.150 |
EBITDA (p.s.) |
-0.963 |
P/E |
-4.93 |
|
Sales Per Share |
0.004 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-2.71 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-13.36 |
P/S |
1490.36 |
|
Operating Margin |
-24896.81 |
Levered Free Cash Flow
(M) |
-7.99 |
P/CF |
-6.06 |
|
|
|
|
|
|
